Pharmaceutical News

RSS

Drug combination has added benefit for patients with melanoma

The German Institute for Quality and Efficiency in Health Care investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with the appropriate comparator therapies for patients with melanoma.

9 Jan 2019

Study confirms increased pneumonia risk with prescription opioids

A study led by researchers at Yale University has shown that taking prescribed opioids increases the risk of pneumonia, irrespective of HIV status.

7 Jan 2019

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D's live biotherapeutic oncology pipeline across a range of cancer settings.

7 Jan 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Commonly prescribed ADHD drug unlikely to increase cardiovascular risks in children

With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder, the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike.

3 Jan 2019

New medications provide better treatment for alcohol use disorders, chronic pain, mood disorders

Helping people with addictions has become a research passion for Purdue University's Richard van Rijn, who is leading a team to make drug discoveries to support millions around the world dealing with alcohol use disorders, chronic pain and mood disorders.

3 Jan 2019

Alzheimer’s Disease: Learning from the Past, Looking to the Future

An interview with Dr. Lloyd Tran, discussing the major barriers to Alzheimer’s research and development over the past 40 years.

From Alzheimer International Society 3 Jan 2019

Court decision to stop further cuts in 340B reimbursements protects patient care

The Dec. 27 federal court injunction stopping further cuts in 340B reimbursements for Medicare Part B drugs to some participating hospitals is a critical step in preserving the role that academic health centers play in providing HIV, viral hepatitis, and other infectious disease treatment and prevention services to patients who otherwise lack care options.

2 Jan 2019

Sexual function in women with vulva pain improved with oral nerve pain medication

Women with chronic pain or discomfort around the vulva showed improved sexual function with an oral nerve pain medication used to treat pain caused by a previous herpes infection as well as fibromyalgia, according to a Rutgers study.

2 Jan 2019

Study finds wide variation in neuraxial analgesia use in pregnant women across the United States

Pain relief for pregnant women in labor is commonly given in the form of epidural, spinal or combined spinal-epidural blockade, which is collectively referred to as neuraxial analgesia.

31 Dec 2018

Researchers review applications, properties, and pharmacological potentials of rose hip

The genus Rosa from family Rosaceae is one of the most widespread species from the family. One species, rose hip, is known as a good source of different types of micronutrients and phytochemicals such as phenolic acids, tannins, and flavonoids. It is known as a traditional treatment in folk medicine.

28 Dec 2018

New review focuses on the structure-activity relationships of flavonoids

ABCB1 in the ABC transporter family also termed as P-glycoprotein, grants the simultaneous resistance of metastatic cancer cells towards various anti-cancer drugs with different targets and diverse chemical structures.

27 Dec 2018

Breast cancer drugs could tackle lung cancers resistant to targeted therapies

A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, suggests a new study in mice from the Francis Crick Institute and the Institute of Cancer Research.

27 Dec 2018

Study: Reactivation of HIV-infected cells depends on its size and cell cycle

Thanks to the development of antiretroviral drugs, human immunodeficiency virus is considered a manageable chronic disease today.

27 Dec 2018

Lupin partners with Abbvie to develop and commercialize new targeted oncology treatments

Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.

25 Dec 2018

Statins reduce the formation of brown adipose tissue

A certain proportion of the adult population has not only white adipose (or fatty) tissue, but also the brown kind. This brown adipose tissue helps to convert sugar and fat into heat. People with brown adipose tissue are better at regulating their body temperature in the winter, and are less likely to suffer from excess weight or diabetes.

21 Dec 2018

Pharmaceutical News

Drug combination has added benefit for patients with melanoma

Study confirms increased pneumonia risk with prescription opioids

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Commonly prescribed ADHD drug unlikely to increase cardiovascular risks in children

New medications provide better treatment for alcohol use disorders, chronic pain, mood disorders

Alzheimer’s Disease: Learning from the Past, Looking to the Future

Court decision to stop further cuts in 340B reimbursements protects patient care

Sexual function in women with vulva pain improved with oral nerve pain medication

Study finds wide variation in neuraxial analgesia use in pregnant women across the United States

Researchers review applications, properties, and pharmacological potentials of rose hip

New review focuses on the structure-activity relationships of flavonoids

Breast cancer drugs could tackle lung cancers resistant to targeted therapies

Study: Reactivation of HIV-infected cells depends on its size and cell cycle

Lupin partners with Abbvie to develop and commercialize new targeted oncology treatments

Statins reduce the formation of brown adipose tissue

New treatment for adults with rare, life-threatening blood disease receives FDA approval

Study shows high rates of antibiotic overuse in patients undergoing common urological procedures

FDA approves new treatment for rare disease of the bone marrow and blood

Combination of statins and Mediterranean diet more effective in reducing cardiovascular mortality risk

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News